CONMED Expands AirSeal® Robotic Solution Indication for Use with Intuitive’s da Vinci 5 Hex Cannula
CONMED Corporation has announced an important expansion to the indicated use of its AirSeal® Robotic Solution, broadening the system’s compatibility across Intuitive’s da Vinci robotic surgery platform. The company said the AirSeal Robotic Solution is now indicated for use with Intuitive’s 8 mm hex cannulas used as part of the da Vinci 5 surgical system.
The expanded indication builds on the product’s existing indication for use with Intuitive’s 8 mm round cannulas. With the addition of the 8 mm hex cannula, the AirSeal Robotic Solution is now indicated for use across Intuitive’s da Vinci X, da Vinci Xi, and da Vinci 5 robotic surgical systems.
The development represents an important milestone for CONMED as the company continues to expand the reach of its insufflation technology within the rapidly developing robotic surgery market. By supporting compatibility with the latest architecture of Intuitive’s da Vinci 5 platform, the expanded indication is expected to provide greater clarity for hospitals, surgeons, and healthcare systems evaluating complementary technologies for robotic-assisted procedures.
Expanded Compatibility Across Robotic Surgery Platforms
The AirSeal Robotic Solution is designed to support insufflation during minimally invasive and robotic surgical procedures. Insufflation plays a critical role in laparoscopic and robotic surgery by creating and maintaining the working space required for surgeons to operate within the body. The ability to maintain a stable surgical environment is particularly important in robotic procedures, where precision, visualization, instrument movement, and workflow efficiency are central to procedural performance.
CONMED’s latest announcement expands the range of Intuitive cannula configurations with which the AirSeal Robotic Solution is indicated for use. Previously, the solution was indicated for use with Intuitive’s 8 mm round cannulas. The addition of the 8 mm hex cannula associated with the da Vinci 5 platform extends the product’s indicated compatibility to Intuitive’s newest robotic surgery system.
As a result, hospitals using different generations of the da Vinci platform may have greater clarity when assessing the role of AirSeal technology within their robotic surgery programs. The expanded indication also reflects the evolving nature of robotic surgery infrastructure, where hospitals increasingly seek technologies that can integrate effectively into established surgical workflows.
Supporting the Growth of Robotic-Assisted Surgery
Robotic-assisted surgery has become an increasingly important part of the broader minimally invasive surgery landscape. Hospitals and surgeons continue to adopt robotic platforms for a growing range of procedures, while manufacturers develop complementary technologies intended to support operating room efficiency and procedural performance.
Within this environment, insufflation technology represents an important component of the surgical ecosystem. A stable and controlled surgical workspace can help surgeons perform procedures with greater consistency, particularly during complex minimally invasive operations. Technologies that can work alongside robotic surgical systems therefore have the potential to play a meaningful role in supporting modern operating room workflows.
CONMED said the expanded indication for the AirSeal Robotic Solution reinforces the company’s position within this growing market. By enabling use with both the 8 mm round cannulas and the 8 mm hex cannula associated with Intuitive’s robotic platforms, the company is strengthening the product’s relevance across a broader range of robotic surgery environments.
The development may also help hospitals better understand how complementary technologies can be used with robotic systems. As healthcare providers continue to invest in robotic surgery platforms, product compatibility and technical clarity are becoming increasingly important factors in purchasing and operational decisions.
Clinical Experience Supporting AirSeal Technology
According to CONMED, the AirSeal Robotic Solution is supported by more than 40 clinical studies demonstrating the benefits of AirSeal technology at low insufflation pressures. This body of clinical experience represents an important part of the company’s efforts to establish the technology’s role in minimally invasive and robotic surgery.
Low-pressure insufflation is an area of continued interest within surgical care because insufflation pressure can influence the surgical environment and the patient experience. The AirSeal technology is intended to support the maintenance of the pneumoperitoneum required for minimally invasive procedures while operating at low insufflation pressures.
CONMED believes this clinical foundation contributes to the differentiation of its AirSeal portfolio. As robotic surgery continues to expand, hospitals and surgeons are increasingly evaluating not only the robotic platform itself but also the technologies that support the broader procedural workflow.
The company’s focus on clinical evidence and technical compatibility is therefore central to its strategy. The expanded indication for use with the da Vinci 5 8 mm hex cannula adds another element to that strategy by addressing compatibility with the latest generation of Intuitive’s robotic surgery platform.
Engineering and Technical Compatibility Testing
CONMED said the expanded indication was supported by extensive engineering and technical compatibility testing conducted by the company in collaboration with Intuitive. Such testing is designed to provide data regarding how the AirSeal Robotic Solution works with the relevant cannula configuration and robotic surgical system.
Technical compatibility is particularly important in modern operating rooms, where surgical technologies from multiple manufacturers may be used together during the same procedure. Hospitals require clear information about how products interact, while surgeons and operating room teams need confidence that supporting technologies can be incorporated into established workflows.
By conducting compatibility testing and communicating the expanded indication, CONMED aims to provide customers with greater clarity regarding the use of AirSeal technology alongside the da Vinci 5 platform.
Patrick J. Beyer, President and Chief Executive Officer of CONMED, said the company was pleased to secure and announce the expanded indication. He noted that the milestone was supported by extensive engineering and technical compatibility testing conducted by CONMED in collaboration with Intuitive.
According to Beyer, the work reflects CONMED’s commitment to ensuring that surgeons and hospitals have access to the necessary compatibility data and clear product communication. He also emphasized the company’s broader goal of supporting healthcare professionals as they seek to deliver high-quality care to patients.
Enhancing Clarity for Hospitals and Surgeons
One of the key benefits of the expanded indication is expected to be greater clarity regarding the use of AirSeal with the da Vinci 5 platform. As robotic surgery systems evolve, hospitals must continuously assess how new platforms interact with existing equipment, accessories, and complementary technologies.
The da Vinci 5 platform represents the latest generation of Intuitive’s robotic surgery technology. The addition of the 8 mm hex cannula to the AirSeal Robotic Solution’s indicated compatibility provides hospitals with additional information when planning their robotic surgery workflows.
For surgeons, compatibility information can help support decision-making when selecting technologies for specific procedures. For hospital administrators and operating room managers, clearly defined compatibility can contribute to equipment planning, procurement, training, and workflow development.
CONMED expects the expanded indication to help clarify how the AirSeal Robotic Solution and the da Vinci 5 platform can be used together to support consistent surgical workflows. The company believes that this clarity may be particularly valuable as hospitals expand robotic surgery programs and seek to standardize technologies across multiple operating rooms.
Potential Impact on Procedural Efficiency
The AirSeal Robotic Solution is also positioned by CONMED as a technology that can support procedural efficiency. Robotic surgery requires coordination among surgeons, nurses, anesthesiologists, technicians, and other operating room personnel. Technologies that integrate smoothly into the surgical environment may help support more consistent workflows.
Although the expanded indication itself is focused on compatibility, the broader strategic significance for CONMED lies in the potential to make AirSeal technology available across a wider range of robotic surgery configurations.
The company believes that the ability to use the AirSeal Robotic Solution with Intuitive’s 8 mm round and 8 mm hex cannulas can support hospitals with diverse robotic surgery platforms. This flexibility may be relevant for healthcare systems that operate multiple generations of da Vinci systems or are transitioning to newer robotic technology.
As hospitals increasingly seek to maximize the value of their capital investments, complementary technologies that can be used across multiple platforms may become increasingly important. CONMED’s expanded indication could therefore support the continued adoption and utilization of its AirSeal portfolio within robotic surgery programs.
Strengthening CONMED’s Position in Medical Devices
The announcement also highlights CONMED’s broader position in the medical devices industry. The company develops and provides medical technologies used across a variety of surgical specialties and healthcare settings. Its AirSeal portfolio is an important part of its efforts to participate in the growth of minimally invasive and robotic-assisted surgery.
The company’s latest milestone demonstrates the importance of product development that extends beyond the creation of standalone medical devices. As surgical technology becomes increasingly interconnected, compatibility between devices and platforms can influence clinical adoption and commercial success.
For CONMED, the expanded AirSeal indication provides an opportunity to align its technology with the latest developments in robotic surgery. The company expects the milestone to contribute to the continued growth potential of the AirSeal portfolio.
Beyer said the expanded indication provides additional confidence in the growth opportunity for AirSeal. The company believes the product’s clinical foundation, technical compatibility, and expanding use across robotic platforms position the portfolio for continued development as robotic surgery adoption increases.
The expansion of the AirSeal Robotic Solution’s indicated use represents a significant development for CONMED’s robotic surgery strategy. With compatibility now expanded to include Intuitive’s 8 mm hex cannula used with the da Vinci 5 platform, the solution has a broader indicated presence across Intuitive’s portfolio of robotic systems.
The milestone reflects the growing importance of interoperability and technical compatibility in modern surgical care. As healthcare systems continue to invest in robotic-assisted surgery, they are likely to place increasing emphasis on technologies that can integrate into established workflows while supporting efficiency, consistency, and clinical performance.
CONMED’s collaboration with Intuitive on engineering and technical compatibility testing also highlights the role of manufacturer cooperation in advancing the use of complementary surgical technologies. Clear compatibility data can help hospitals and surgeons make more informed decisions when building and expanding robotic surgery programs.
With more than 40 clinical studies supporting the benefits of AirSeal technology at low insufflation pressures, CONMED is positioning the expanded indication as another step in the development of its robotic surgery portfolio.
The company will now seek to build on this momentum as demand for robotic-assisted procedures continues to grow. By expanding the indicated use of the AirSeal Robotic Solution to include the 8 mm hex cannula used with the da Vinci 5 system, CONMED aims to provide customers with greater flexibility and clarity while strengthening its position in the competitive medical devices and robotic surgery markets.
Source link: https://www.businesswire.com/
